cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumors.
Saved in:
| Title: | cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumors. |
|---|---|
| Authors: | Wesseling P; Department of Pathology, Amsterdam University Medical Centers/VU University Medical Center, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Capper D; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Humboldt-Universität and Freie Universität Berlin, Berlin, Germany.; German Cancer Research Center, German Cancer Consortium, Partner Site Berlin, Heidelberg, Germany., Reifenberger G; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Düsseldorf, Germany.; German Cancer Consortium, Partner Site Essen/Düsseldorf, Düsseldorf, Germany., Sarkar C; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India., Hawkins C; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada., Perry A; Department of Pathology, UCSF, San Francisco, California, USA.; Department of Neurological Surgery, UCSF, San Francisco, California, USA., Kleinschmidt-DeMasters B; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA., Komori T; Department of Laboratory Medicine and Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan., Paulus W; Institute of Neuropathology, University Hospital Munster, Munster, Germany., Santosh V; National Institute of Mental Health and Neurosciences, Bengaluru, India., van den Bent M; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Pfister SM; Division of Pediatric Neurooncology, German Cancer Research Center, German Cancer Consortium, Heidelberg, Germany.; Hopp Children's Cancer Center, Heidelberg University Hospital, NCT Heidelberg, Heidelberg, Germany., Tabori U; Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada., Figarella-Branger D; Service d'Anatomie Pathologique et de Neuropathologie, Hôpital de la Timone, Institut de Neurophysiopathology, Aix-Marseille Univ, APHM, CNRS, Marseille, France., Orr BA; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Louis DN; Department of Pathology, Massachusetts General Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | Brain pathology (Zurich, Switzerland) [Brain Pathol] 2026 Jan; Vol. 36 (1), pp. e70035. Date of Electronic Publication: 2025 Aug 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Society of Neuropathology Country of Publication: Switzerland NLM ID: 9216781 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-3639 (Electronic) Linking ISSN: 10156305 NLM ISO Abbreviation: Brain Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1750-3639 |
|---|---|
| DOI: | 10.1111/bpa.70035 |
